Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|August 2, 2021
A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal CancerMahnoor Naseer Gondal, Rida Nasir Butt, Osama Shiraz Shah, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cellsNathalie Bouloc, Jonathan M Large, Magda Kosmopoulou, et al.
Frontiers in Chemistry|July 18, 2024
Discovery and prospects of new heterocyclic Isatin-hydrazide derivative with a novel role as estrogen receptor α degrader in breast cancer cellsMuhammad Nouman Arif, Sadia Sarwar, Farhat Firdous, et al.
Molecular Cancer Therapeutics|September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivoAmir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.
Bioorganic Chemistry|January 10, 2024
Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agentSana Iqbal, Farhat Firdous, Muhammad Furqan, et al.
Journal of Natural Products|June 10, 2022
Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase InhibitorsMuhammad Furqan, Alishba Fayyaz, Farhat Firdous, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2015
7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituentVassilios Bavetsias, Yolanda Pérez-Fuertes, Patrick J McIntyre, et al.
Plos One|June 30, 2025
Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological propertiesShafia Parveen, Shazia Iqbal, Saima Maher, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Design, Synthesis, and Biological Evaluation of SSE1806, a Microtubule Destabilizer That Overcomes Multidrug ResistanceFarhat Firdous, Sharon Riaz, Muhammad Furqan, et al.
Scientific Reports|April 29, 2025
CanSeer: a translational methodology for developing personalized cancer models and therapeuticsRida Nasir Butt, Bibi Amina, Muhammad Umer Sultan, et al.
Pageof 8